title: Mutations in CDKN2C (p18) and CDKN2D (p19) may cause sporadic parathyroid adenoma.
authors.affiliation: Genetics and Endocrinology Section, Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bld 10, Room 9C-103, 10 Center Drive, Bethesda, Maryland, 20892, USA Departments of Surgery and Genetics, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, New York, 10461, USA.
authors.forename: Thomas
authors.initials: T
authors.lastname: Gluick
authors.forename: Ziqiang
authors.initials: Z
authors.lastname: Yuan
authors.forename: Steven K
authors.initials: SK
authors.lastname: Libutti
authors.forename: Stephen J
authors.initials: SJ
authors.lastname: Marx
mesh_terms: D000236:Adenoma / Q000235:genetics* / Q000601:surgery; D050763:Cyclin-Dependent Kinase Inhibitor p18 / Q000235:genetics*; D050764:Cyclin-Dependent Kinase Inhibitor p19 / Q000235:genetics*; D006801:Humans; D009154:Mutation / Q000235:genetics*; D010282:Parathyroid Neoplasms / Q000235:genetics* / Q000601:surgery
chemical_list: C493971:CDKN2C protein, human; C493974:CDKN2D protein, human; D050763:Cyclin-Dependent Kinase Inhibitor p18; D050764:Cyclin-Dependent Kinase Inhibitor p19